Guangzhou Fanen Biotechnology

Developer of T-cell therapies for the treatment of solid tumors

placeGuangzhou, Guangdong, China calendar_todayFounded 2016 language fineimmu.com

Innovation

4 patent families — focus: Chemistry & metallurgy; filing pace accelerating. Cited 10 times.

YearFilings
20231
20253

Investor mix

3 investors on record; lead investors include Yunxiu Capital.

Investor typeCountShare
Venture capital133%
Bank & private debt133%
Other / undisclosed133%
Coming soon